|Articles|May 15, 2017
- BioPharm International-05-15-2017
- Volume 2017 eBook
- Issue 1
Operations and Quality Oversight of CMOs
Author(s)Hope Mueller
Effective communication between contract manufacturing organizations and pharmaceutical company clients relies on well-defined master service and quality agreements.
Advertisement
CMO partnerships can be challenging both for the CMO and the product owner. The article maps out optimal organizational designs for CMOs and product owners that increase the likelihood of a successful partnership and ensure consistent, reliable, and quality supply of drug product.
Download BioPharm International's
.
Articles in this issue
over 8 years ago
Customer Relationship Management in Contract Manufacturingover 8 years ago
Getting Biopharmaceutical Tech Transfer Right the First Timeover 8 years ago
CMOs Tackle New Challengesover 8 years ago
Gearing Up for Biosimilarsover 8 years ago
Insourcing vs Outsourcing: Choosing the Right Strategyover 8 years ago
Quality Metrics and CMO AgreementNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
4
$1.8M RedHill Deal Highlights Growing Worldwide Focus on H. pylori Treatment Access
5
